- The program began with a robotic left internal mammary artery (“LIMA”) take-down performed by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, using the SSi Mantra advanced robotic surgical system from SS Innovations.
- SS Innovations reported 238 SSi Mantra systems installed as of September 8, up 42% from the end of 2025.
- The system is now installed across 12 countries, with recent expansion into Colombia, Sri Lanka and the Philippines.
- SS Innovations is pursuing U.S. FDA review and European Union CE marking as it seeks to expand SSi Mantra into additional international markets.
SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has expanded the clinical footprint of its SSi Mantra surgical robotic system with the launch of a robotic cardiac surgery program at HCG Hospital, Mithakhali, in Ahmedabad, India. The program began with a robotic cardiac surgery LIMA take-down performed using the SSi Mantra 3.0 system. The procedure was led by Dr. Brajmohan Singh and proctored by Dr. Lalit Malik, with support from the SS Innovations team.
“We congratulate Dr. Brajmohan Sinh, Dr. Lalit Malik, and the entire team at HCG Hospital for this achievement, and thank them for their trust and commitment in advancing robotic cardiac surgery in the region,” the company wrote in a LinkedIn post (https://nnw.fm/Wz3pv). “At SS Innovations International, Inc. we remain committed to enabling hospitals and surgical teams across the country to bring advanced, affordable robotic surgery to more patients, in more places.”
The Ahmedabad deployment adds another cardiac program to an installed base that is increasingly being used across specialties and geographies. The announcement comes shortly after SS Innovations reported that 238 SSi Mantra systems had been installed as of September 8, compared with 168 at the end of 2025. That represents a 42% increase in the installed base during the period.
Procedure volumes have grown more rapidly. The company reported 14,103 cumulative multi-specialty procedures using SSi Mantra as of September 8, up from 7,885 at the end of 2025, an increase of 79%. Approximately 1,500 physicians have been trained on the system, which has been used for more than 170 different types of surgical procedures.
The figures provide a measure of the operating base SS Innovations has established in India while the company works to replicate that model internationally. In July, SS Innovations launched a robotic cardiac surgery program at La Fundación Cardiovascular de Colombia in Bucaramanga. The program included Colombia’s first Totally Endoscopic Beating-Heart Bypass Surgery performed using SSi Mantra.
In August, Kings Hospital Colombo installed the first SSi Mantra system in Sri Lanka. The company subsequently reported the country’s first robotic-assisted cardiac surgery using the platform, followed by more than 25 additional robotic procedures during the system’s first three weeks of operation.
With the Sri Lankan installation, SS Innovations said the SSi Mantra’s installed base had reached 12 countries.
The company is also extending the platform into pediatric procedures. On August 14, SSi Mantra and 5-millimeter instruments were used for a robotic pyeloplasty on a 45-day-old infant at Hindusthan Hospital in Coimbatore, India. SS Innovations reported 258 cumulative pediatric robotic surgeries as of August 31.
Telesurgery represents another developing application. As of August 31, the company reported 188 robotic telesurgeries using SSi Mantra. One July procedure connected surgeons at Hospital Internacional de Colombia in Bucaramanga with a patient at Mohak Bariatrics and Robotics in Indore, India, across more than 13,600 miles of fiber-network distance.
In September, SSi Mantra was also used for what the company described as the first telesurgery within the Philippines, connecting Pampanga and Cotabato across approximately 1,710 kilometers.
SS Innovations is positioning SSi Mantra around both advanced surgical capabilities and accessibility. The platform is a modular system with three to five robotic arms, a 3D 4K visualization system and more than 40 types of robotic endo-surgical instruments, according to the company. Its product range also includes the SSi Mudra instrument portfolio and the portable MantrAsana tele-surgeon console.
The next major development area is regulatory expansion. SS Innovations submitted its SSi Mantra 510(k) premarket notification to the U.S. Food and Drug Administration in December 2025. The company now expects the FDA review to be completed by the end of the first quarter of 2027. It also believes the SSi Mantra can obtain European Union CE marking by the end of 2026.
For more information, visit the company’s website at www.SSInnovations.com.
NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://nnw.fm/SSII
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer
NetworkNewsWire
Austin, Texas
www.NetworkNewsWire.com
512.354.7000 Office
[email protected]
NetworkNewsWire is powered by IBN
